Application of the resource-based relative value scale system to pediatrics

    Pediatrics
    |December 3, 2008
    PubMed

    Insights

    Understanding the Medicare Resource-Based Relative Value Scale (RBRVS) is crucial for healthcare payment and productivity. While widely adopted, the RBRVS may not fully represent pediatric services, prompting ongoing advocacy for equitable adjustments.

    Area of Science:

    • Health economics
    • Medical practice management
    • Public health policy

    Background:

    • The Medicare Resource-Based Relative Value Scale (RBRVS) physician fee schedule is a foundational element in healthcare reimbursement.
    • RBRVS principles are widely adopted by third-party payers, including Medicaid and commercial insurers, for physician payment.
    • Group practices utilize RBRVS for benchmarking physician productivity and determining compensation.

    Purpose of the Study:

    • To examine the genesis and principles of the Medicare RBRVS physician fee schedule.
    • To identify potential underrepresentation of pediatric care within the RBRVS framework.
    • To discuss the implications for physician payment and productivity measurement in pediatrics.

    Main Methods:

    • Analysis of the foundational principles and structure of the Medicare RBRVS.
    • Review of the application of RBRVS by various healthcare payers and practice groups.
    • Assessment of the specific considerations for pediatric services within the RBRVS system.

    Main Results:

    • The Medicare RBRVS is the predominant system for physician payment across numerous payers.
    • Certain pediatric services may have their unique physician work and practice expenses inaccurately reflected in RBRVS total relative value units (RVUs).
    • The American Academy of Pediatrics supports Current Procedural Terminology (CPT) codes and the RBRVS as a uniform system but seeks to address inequities.

    Conclusions:

    • The RBRVS physician fee schedule is a critical, widely used payment system in healthcare.
    • Potential inequities exist in the RBRVS for pediatric services, necessitating continued efforts for accurate valuation.
    • The American Academy of Pediatrics advocates for the uniform RBRVS system while working to resolve specific pediatric concerns.

    Related Concept Videos

    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Relative Risk01:12

    Relative Risk

    Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Assessment of Ventilation I: Respiratory Rate01:20

    Assessment of Ventilation I: Respiratory Rate

    Assessment of Ventilation
    A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
    Critical Guidelines for Assessing Ventilation: